The UK's developing landscape of mind-altering substances is witnessing a remarkable shift, extending far past the traditional focus on magic mushrooms and lysergic acid diethylamide. Excitement is increasingly directed on newer compounds, such as dimethyltryptamine, CBG a cannabinoid showing pot